The Chilean National Consumer Service (Sernac) has released a study on e-cigarettes on November 30th. The study analyzes the risks and quality standards of these products, as well as their regulatory framework within the country. Sernac has received nearly 170 complaints regarding e-cigarette vaporizer products in recent years.
Sernac has conducted a total of 558 reviews of e-cigarettes or vaporizers sold online, which were offered by 16 companies and correspond to 56 brands. The offline investigation involved 16 companies, corresponding to 14 brands and 80 different models.
All the products analyzed lack proper sanitary registration, including those that openly claim to be nicotine-free. Additionally, the analyzed brands have failed to adhere to the requirement of providing "health warnings" in their reports, with only 21% of brands obliging to "recommend keeping the products out of the reach of children.
From January 2018 to January 2023, a total of 171 cases related to e-cigarette products were recorded by Sernac.
The companies with the highest number of complaints are Vaporizadores Chile (11.7%), Santivape (8.8%), Quema Smokeshop (8.2%), Zigzaboo (7.6%), Tigo Vape (6.4%), Freesmoke (5.8%), chileVapea (2.9%), and Vapea Chile (2.3%).
In consumer complaints, contract issues top the list, accounting for 62% of the total. Examples include delayed delivery of purchased products, which accounts for 17% of the complaints.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
